246 related articles for article (PubMed ID: 18543294)
1. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
Chen Z; Lu Y; Qi J; Wu W
Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
[TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
5. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
7. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
9. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
10. Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture.
Zoppetti G; Puppini N; Ospitali F; Fini A
J Pharm Sci; 2007 Jul; 96(7):1729-36. PubMed ID: 17514727
[TBL] [Abstract][Full Text] [Related]
11. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
12. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
Fini A; Ospitali F; Zoppetti G; Puppini N
Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
[TBL] [Abstract][Full Text] [Related]
13. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
[TBL] [Abstract][Full Text] [Related]
14. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.
Lu Y; Guo T; Qi J; Zhang J; Wu W
AAPS PharmSciTech; 2012 Dec; 13(4):1222-9. PubMed ID: 22968546
[TBL] [Abstract][Full Text] [Related]
16. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
18. Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets.
Lust A; Lakio S; Vintsevits J; Kozlova J; Veski P; Heinämäki J; Kogermann K
Int J Pharm; 2013 Nov; 456(1):41-8. PubMed ID: 23994016
[TBL] [Abstract][Full Text] [Related]
19. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
20. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
